and orforglipron, an oral nonpeptide GLP-1 receptor agonist
Are the new weight loss drugs too good to be true? Summer 2024
The latest block includes a swathe of smaller companies such as Strut Health, PharmaZee, Lean Rx, and influencer and TV personality Savannah Chrisley's GoodGirlRx that are operating weight-loss programmes based on providing compounded versions of Novo Nordisk's GLP-1 agonists semaglutide and liraglutide and Lilly's dual GIP/GLP-1 agonist tirzepatide
Injections, such as Zepbound and Wegovy, often provide higher weight loss efficiency, while oral options like Wegovy and Foundayo offer a simple daily pill routine
This is to avoid any problems with digestion
Many people find they need conscious effort to drink enough because thirst decreases along with appetite